STATE COLLEGE, PA, UNITED STATES, July 29, 2025 /EINPresswire / -- INDIGO Biosciences, a global leader in cell-based assay solutions, announced today the expansion of its alternative species line with ...

GLP-1 receptor agonists and amylin receptor agonists have shown clinically relevant weight loss and glucose-lowering effects in people with overweight, obesity, and type 2 diabetes. Amycretin is a ...

BU researchers have now discovered that exosomes—messenger nanovesicles  that carry proteins, RNA, and other molecules to other cells—released into the blood by different organs and tissues in obese, ...